MED: Heart Failure Update: What’s New and How to Optimize Therapy, 10/27/17

October 27, 2017

Target Audience

Primary Care Providers

Learning Objectives

After participation in this CME activity, the learner will be able to:

  1. Discuss the current guideline based indications for use of heart failure biomarkers
  2. Incorporate the use of new pharmacotherapies with existing therapies for HFrEF
  3. Identify therapies that should be avoided and/or are not effective in heart failure patients
  4. Treat important comorbid conditions in patients with heart failure

Additional Information

San Francisco Medical Center
Conference room: 
2238 Geary Blvd. Diamond Room
Course summary
Available credit: 
  • 1.00 AMA PRA Category 1 Credit(s)™
  • 1.00 Attendance
Course opens: 
Course expires: 
Event starts: 
10/27/2017 - 12:30pm PDT
Event ends: 
10/27/2017 - 1:30pm PDT
San Francisco Medical Center
2238 Geary Blvd
3rd FL, Diamond
San Francisco , CA
United States

Planner: Bella Seerke, MD

Speaker:  Dana McGlothlin, MD

Disclousure Statement: The faculty and the CME planners for this activity, as well as the CME staff, do not have any relevant financial relationshpis with comercial intersts or affiliations to disclose.

The Kaiser San Francisco (San Francisco, CA 94115) is accredited by the Institute for Medical Quality/California Medical Association (IMQ/CMA) to provide continuing medical education for physicians.

Available Credit

  • 1.00 AMA PRA Category 1 Credit(s)™
  • 1.00 Attendance
Please login or register to take this course.